Ranbaxy Laboratories Ltd has announced that a meeting of the Board of Directors of the Company will be held on October 18, 2007, inter alia, to consider Unaudited Financial Results (Provisional) for the third quarter ended September 30, 2007 (Q3) and payment of Interim Dividend on Equity Shares of the Company.
